Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy

Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy

PURPOSE: Hepatocellular carcinoma (HCC) is one of the most severe complications in chronic hepatitis B virus (HBV) infection. HCC can still develop in patients with chronic HBV (CHB) infection undergoing antiviral therapy. Several effective scoring systems for the prediction of HCC risk in CHB patie...

Full description

Bibliographic Details
Main Authors: Chih-Lang Lin, Szu-Yuan Wu, Ming-Wei Lai, Chao-Wei Hsu, Wan-Ming Chen, An-Tzu Jao, Cheng-Hung Chien, Ching-Chih Hu, Rong-Nan Chien, Chau-Ting Yeh
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
hepatocellular carcinoma
antiviral therapy
hepatitis B virus
predictive scoring
nucleos(t)ide analogue
Online Access:https://www.mdpi.com/2072-6694/15/13/3343

Internet

https://www.mdpi.com/2072-6694/15/13/3343

Similar Items